Murine Ornithine Transcarbamylase: Structure and Expression
The hepatic enzyme ornithine transcarbamylase (OTC) (EC 188.8.131.52) catalyses the condensation of carbamyl phosphate and ornithine to form citrulline (Gisolia and Cohen, 1952; Jones et al., 1961). This is the second step of the mammalian urea cycle involved in the detoxification of ammonia and biosynthesis of urea. OTC is encoded on the X chromosome (Lindgren et al., 1984) and expressed primarily in liver and to a lesser extent in small bowel. The enzyme is synthesized in the cytoplasm as a 41 kD precursor and then transported to the mitochondria where a 32 amino acid leader peptide is cleaved and trimers associate within the matrix to form the active enzyme (Conboy et al., 1979; Mori et al., 1982). OTC deficiency is the most common urea cycle defect in humans and results in a severe and often fatal neonatal ammonia intoxication in hemizygous males (Walser, 1983). Female heterozygotes display a variable phenotype based on the severity of the mutation and random X-chromosome inactivation. Treatment of affected infants has been confined to restricted protein intake, peritoneal dialysis and administration of amino acid acylating agents such as benzoate, butyrate, or phenylacetate (Batshaw, 1982; Batshaw, 1981; Brusilow et al. 1984). Long-term outlook, particularly for affected males is poor, evidenced by the high incidence of mental retardation and cerebral palsy while hyperammoneimic episodes often lead to coma and death (Msall et al., 1984). Prenatal diagnosis has been largely confined to restriction fragment length polymorphism (RFLP) analysis (Fox et al., 1986; Nussbaum et al., 1986) as amniocytes do not express the enzyme, there are no metabolic products of the disorder present in amniotic fluid, and fetal liver biopsy poses a high risk to both mother and fetus.
KeywordsChloramphenicol Acetyl Transferase Ornithine Transcarbamylase Chloramphenicol Acetyl Transferase Activity Ornithine Carbamoyl Transferase Chloramphenicol Acetyl Transferase Expression
Unable to display preview. Download preview PDF.
- Costa, R.H., Grayson, D.R., Zanthopoulos, K.G., and Darnell, S.E., 1988, A liver-specific DNA binding protein recognizes multiple nucleotide sites in regulatory regions of transthyretin, α 1-antitrypsin, albumin, and simian virus 40 genes, Proc. Natl. Acad. Sci. USA, 85:3840.PubMedCrossRefGoogle Scholar
- Hogan, B.L.M., Constantini, F., and Lacy, L., 1986, “Manipulating the Mouse Embryo: A Laboratory Manual,” Cold Spring Harbor Laboratory, Cold Spring Harbor.Google Scholar
- Maniatis, T., Fritsch, E.F., and Sambrook, J., 1982, “Molecular Cloning: A Laboratory Manual,” Cold Spring Harbor Laboratory, Cold Spring Harbor.Google Scholar
- Mori, M., Miura, S., Morita, T., Takiguchi, M., and Tatibana, M., 1982, Ornithine transcarbamylase in liver mitochondria, Mol. Cell Bioch. 49:97.Google Scholar
- Nussbaum, R.L., Boggs, B.A., Beaudet, A.L., Doyle, S., Potter, J.L., and O’Brien, W.E., 1986, New mutation and prenatal diagnosis in ornithine transcarbamylase deficiency, Am. J. Human. Genet. 38:149.Google Scholar
- Veres, G., Craigen, W.J., and Caskey, C.T., 1985. The 5′ flanking region of the ornithine transcarbamylase gene contains DNA sequences regulating tissue-specific expression, J. Biol. Chem., 261:7588.Google Scholar
- Walser, M., 1983, Urea cycle disorders and other hereditary hyperammonemic syndromes, in: “The Metabolic Basis of Inherited Disease,” J.B. Stanbury, J.B. Wyngaarden, D.S. Fredrickson, J.L. Goldstein, M.S. Brown, eds., McGraw-Hill, New York.Google Scholar
- Wong, G.G., Witek, J.S., Temple, P.A., Wilkens, K.M., Leary, A.C., Luxenberg, D.P., Jones, S.S., Brown, E.L., Kay, R.M., Orr E.C., Shoemaker, C., Golde, D.W., Kaufman, R.J., Hewick, R.M. Wang, E.A., and Clark, S.C., 1985, Human GM-CSF: molecular cloning of the complementary DNA and purification of the natural and recombinant proteins, Science, 228:810.PubMedCrossRefGoogle Scholar